As the tenth most common cancer in the world, scientists are working hard to deliver treatments to alleviate the impact of bladder cancer on patients
The current standard of treatment for these patients includes a high-burden version of chemotherapy, followed by radical cystectomy. On top of that, the bladder permeability barrier often makes it difficult for medications to make their way to the tumor. This podcast — provided by Janssen — explains how innovative technologies within the field are changing that.
Check out the podcast episodes below.⬆
- Ep. 3 The Transformation of Bladder Cancer Treatments and Role of Genetic Alterations
- Ep. 2 A Clinician's Journey Pt. II
- Ep. 1 A Clinician's Journey Pt. I
The Transformation of Bladder Cancer Treatments and Role of Genetic Alterations
In the third episode of Breaking Down Barriers, Dr. Pat Keegan, Senior Medical Director for Janssen Research & Development, discusses the different types of bladder cancer and the importance of genetic testing when determining treatment options.